HOME › DRUGS › ABACAVIR SULFATE
ACTIVE SUBSTANCE / INN

ABACAVIR SULFATE

Brand name(s): TRIUMEQ PD, ABACAVIR SULFATE AND LAMIVUDINE, ABACAVIR SULFATE; LAMIVUDINE, ZIAGEN, TRIZIVIR, ABACAVIR SULFATE, ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
NDA202007
NDA204311
ACTIVE SUBSTANCE
Abacavir Sulfate
REGULATORS
FDA
SPONSORS / MAH
MYLAN PHARMA, LUPIN LTD, PHARMOBEDIENT
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ABACAVIR SULFATEANDA091050CHARTWELL RXPrescription
ABACAVIR SULFATE; LAMIVUDINENDA202007CIPLA LIMITEDNone (Tentative Approval)
ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINEANDA202912LUPIN LTDDiscontinued
ABACAVIR SULFATE AND LAMIVUDINENDA204311PHARMOBEDIENTDiscontinued
TRIUMEQ PDNDA215413VIIV HLTHCAREPrescription
ABACAVIR SULFATENDA022547CIPLA LIMITEDNone (Tentative Approval)
ABACAVIR SULFATE AND LAMIVUDINEANDA091144CIPLAPrescription
ZIAGENNDA020978VIIV HLTHCAREPrescription
ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINEANDA090309MYLAN PHARMANone (Tentative Approval)
TRIZIVIRNDA021205VIIV HLTHCAREDiscontinued

FULL INTELLIGENCE ON ABACAVIR SULFATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →